Search Results for: medical

Misconduct at Oxford prompts retraction of insulin paper

Cell Metabolism has retracted a 2006 article by a group of researchers at Oxford in England after an investigation concluded that the first author had committed misconduct. The paper, “Nicotinamide nucleotide transhydrogenase: A key role in insulin secretion,” came from the lab of Frances Ashcroft, a world-renowned expert on ion channels. (We’ve written about Ashcroft’s … Continue reading Misconduct at Oxford prompts retraction of insulin paper

Citation manipulation: Journal retracts paper because author boosted references to a journal he edits

A group of researchers have lost a paper in a computer science journal because they were apparently using its references to help the impact factor of a different journal that one of them edits. Here’s the notice for “Impacts of sensor node distributions on coverage in sensor networks,” a paper first published in 2011 and … Continue reading Citation manipulation: Journal retracts paper because author boosted references to a journal he edits

DMCA notice forces removal of post critical of author who threatened to sue Retraction Watch

A blog post at another site that picked up on our coverage of Benjamin Jacob Hayempour, the researcher who has two retractions and has threatened to sue us, has been removed following a Digital Millenium Copyright Act (DMCA) takedown notice. As Andrew Oh-Willkie, the blogger, writes in an account of the incident:

Biotech company retracts Parkinson’s treatment study after “possible deviation from protocol”

Living Cell Technologies (LCT), a biotech company headquartered in Australia, has retracted a 2011 paper purporting to show that their product reversed Parkinson’s symptoms in rats after “being unable to reconfirm their reported results and a possible deviation from the protocol.” LCT is developing NTCELL, which, according to their site:

A rating system for retractions? How various journals stack up

Here at Retraction Watch, we judge retraction notices every day. We even have a category called “unhelpful retraction notices.” But we haven’t systematically analyzed those notices, so lucky for us, a group of academics at Vanderbilt decided to. In a new paper published in a special issue of Publications — an issue whose editor, Grant … Continue reading A rating system for retractions? How various journals stack up

Weekend reads: Trying unsuccessfully to correct the scientific record; drug company funding and research

There were lots of pieces about scientific misconduct, publishing, and related issues posted around the web this week, so without further ado:

Journal reveals real reason for retraction of paper by author who threatened to sue Retraction Watch

Last week, we reported on the retraction of a paper by Benjamin Jacob Hayempour, a researcher who had threatened to sue us last month for even reporting on another of his retractions. The journal, Cureus, told us at the time that the retraction — in which the article disappeared, without a notice — didn’t have … Continue reading Journal reveals real reason for retraction of paper by author who threatened to sue Retraction Watch

Is it ethical to ghost-write a paper?

Another installment of Ask Retraction Watch: I am a postdoc and looking to supplement my income with medical writing (our lab recently didn’t get it’s funding renewed, so now on part-time to minimise costs). The most recent jobs I have been offered are two brief reports and one full article. A quick internet search of … Continue reading Is it ethical to ghost-write a paper?

Quickest withdrawal ever? Journal yanks paper alleging 800K deaths from Poldermans affair

Just 48 hours after publishing an article by Graham Cole and Darrel Francis last week alleging that Don Poldermans‘ scientific misconduct led to the deaths of some 800,000 Europeans over the past five years by tainting clinical guidelines, the European Heart Journal unceremoniously pulled the paper from its website Friday. Larry Husten at CardioBrief has … Continue reading Quickest withdrawal ever? Journal yanks paper alleging 800K deaths from Poldermans affair

Japan officials allege data cooking in Alzheimer’s drug study

Japanese health officials are reportedly investigating whether researchers fabricated data in a 2.8 billion yen ($21.12 million) Alzheimer’s drug trial. According to Japan Today: Health officials said they were questioning researchers after being told false data was used in clinical testing for the 2.8 billion yen government-backed Alzheimer’s study, aimed at improving diagnosis of the … Continue reading Japan officials allege data cooking in Alzheimer’s drug study